Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 5, 2007
Potential outcome measures and trial design issues for multiple system atrophy
Susanne May, Sid Gilman, B Brooke Sowell, et al.
The Journal of Infectious Diseases
|
December 5, 2022
Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction
Hyon S Hwang, Che-Min Lo, Michael Murphy, et al.
Journal of Virology
|
January 4, 2024
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Mireille Farjo, Katia Koelle, Michael A Martin, et al.
Cell Reports
|
January 16, 2025
Probing the functional constraints of influenza A virus NEP by deep mutational scanning
Qi Wen Teo, Yiquan Wang, Huibin Lv, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 29, 2023
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
Christopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Immunity
|
November 15, 2023
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase
Ruipeng Lei, Wooseob Kim, Huibin Lv, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 26, 2023
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
Christopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>
Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
The Journal of Infectious Diseases
|
June 30, 2021
Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection
Rebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection
Rebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 5, 2007
Potential outcome measures and trial design issues for multiple system atrophy
Susanne May, Sid Gilman, B Brooke Sowell, et al.
The Journal of Infectious Diseases
|
December 5, 2022
Characterizing SARS-CoV-2 Transcription of Subgenomic and Genomic RNAs During Early Human Infection Using Multiplexed Droplet Digital Polymerase Chain Reaction
Hyon S Hwang, Che-Min Lo, Michael Murphy, et al.
Journal of Virology
|
January 4, 2024
Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection
Mireille Farjo, Katia Koelle, Michael A Martin, et al.
Cell Reports
|
January 16, 2025
Probing the functional constraints of influenza A virus NEP by deep mutational scanning
Qi Wen Teo, Yiquan Wang, Huibin Lv, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 29, 2023
First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
Christopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Immunity
|
November 15, 2023
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase
Ruipeng Lei, Wooseob Kim, Huibin Lv, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 26, 2023
Correction: First-in-human phase 1 clinical trial of anti-core 1 O-glycans targeting monoclonal antibody NEO-201 in treatment-refractory solid tumors
Christopher B Cole, Maria Pia Morelli, Massimo Fantini, et al.
Biorxiv : the Preprint Server for Biology
|
September 10, 2020
Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 <i>in vitro</i>
Nir Drayman, Krysten A Jones, Saara-Anne Azizi, et al.
The Journal of Infectious Diseases
|
June 30, 2021
Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection
Rebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 1, 2021
Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection
Rebecca L Smith, Laura L Gibson, Pamela P Martinez, et al.
Page
of 9